Alzheimer's Biomarkers, Ebola Travel Suspensions, and AI in Medical Admissions episode artwork

EPISODE · May 29, 2026 · 13 MIN

Alzheimer's Biomarkers, Ebola Travel Suspensions, and AI in Medical Admissions

from Morning Medical with Dr. Chow · host Chi-Ming Chow

In this episode, Dr. Chi-Ming Chow delves into the early signs of Alzheimer's disease, examining the impact and limitations of current biomarkers and the role of demographic factors and blood-based biomarkers. He discusses Canada's travel suspensions amid the Ebola outbreak, highlighting the measures taken and the criticisms faced. The episode also explores brain changes related to speech comprehension and cognitive decline, focusing on the limitations and implications of a recent speech-in-noise study. Dr. Chow considers the influence of AI on medical school admissions, touching on authenticity, letters of recommendation, and the activities section, as well as the impact on secondary essays. The episode wraps up with Dr. Chow's closing remarks.

Episode metadata supplied by the publisher feed · Published May 29, 2026

Embed this episode

NOW PLAYING

Alzheimer's Biomarkers, Ebola Travel Suspensions, and AI in Medical Admissions

0:00 13:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morning Medical with Dr. Chow?

This episode is 13 minutes long.

When was this Morning Medical with Dr. Chow episode published?

This episode was published on May 29, 2026.

Can I download this Morning Medical with Dr. Chow episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!